Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Endosc ; 53(3): 276-285, 2020 May.
Article in English | MEDLINE | ID: mdl-32506894

ABSTRACT

The area of endoscopic application has been continuously expanded since its introduction in the last century and the frequency of its use also increased stiffly in the last decades. Because gastrointestinal endoscopy is naturally exposed to diseased internal organs and contact with pathogenic materials, endoscopy mediated infection or disease transmission becomes a major concern in this field. Gastrointestinal endoscopy is not for single use and the proper reprocessing process is a critical factor for safe and reliable endoscopy procedures. What needed in these circumstances is a practical guideline for reprocessing the endoscope and its accessories which is feasible in the real clinical field to guarantee acceptable prevention of pathogen transmission. This guideline contains principles and instructions of the reprocessing procedure according to the step by step. And it newly includes general information and updated knowledge about endoscopy-mediated infection and disinfection. Multiple societies and working groups participated to revise; Korean Association for the Study of the Liver, the Korean Society of Infectious Diseases, Korean College of Helicobacter and Upper Gastrointestinal Research, the Korean Society of Gastroenterology, Korean Society of Gastrointestinal Cancer, Korean Association for the Study of Intestinal Diseases, Korean Pancreatobiliary Association, the Korean Society of Gastrointestinal Endoscopy Nurses and Associates and Korean Society of Gastrointestinal Endoscopy. Through this cooperation, we enhanced communication and established a better concordance. We still need more researches in this field and fill up the unproven area. And our guidelines will be renewed accordingly.

2.
Gastrointest Endosc ; 87(3): 789-799.e4, 2018 Mar.
Article in English | MEDLINE | ID: mdl-28939500

ABSTRACT

BACKGROUND AND AIMS: Education on preparation is essential for successful colonoscopy. This study aimed to evaluate the impact of audiovisual (AV) re-education via a smartphone on bowel preparation quality before colonoscopy. METHODS: A prospective, endoscopist-blinded, randomized, controlled study was performed. Patients who underwent colonoscopy with 3 purgatives, including 4 L of polyethylene glycol (4-L PEG), 2 L of PEG with ascorbic acid (2-L PEG/Asc), and sodium picosulfate with magnesium citrate (SPMC), were enrolled and randomized into the AV re-education via smartphone group (AV group, n = 160) and a control group (n = 160). The primary outcome was the quality of the bowel preparation according to the Boston Bowel Preparation Scale (BBPS). The secondary outcomes included instruction adherence using adherence score (AS) and patient satisfaction with education using a visual analog scale (VAS). RESULTS: A total of 283 patients (AV group, n = 139; control group, n = 144) were analyzed per protocol. The mean BBPS (7.53 vs 6.29, P < .001) and the proportion with adequate preparation were higher in the AV group. The mean BBPS of the AV group was significantly higher than that of the control group for the 2-L PEG/Asc and SPMC preparations, but not for the 4-L PEG preparation. The mean AS and the mean VAS score were all significantly higher in the AV group. Among the 3 purgatives, the mean AS was lowest in the 4-L PEG group (P = .041). CONCLUSIONS: AV re-education via smartphone was easy and convenient, and enhanced preparation quality, patient adherence to instructions, and patient satisfaction.


Subject(s)
Cathartics/administration & dosage , Colonoscopy/methods , Patient Compliance/statistics & numerical data , Patient Education as Topic/methods , Adult , Aged , Aged, 80 and over , Ascorbic Acid/administration & dosage , Citrates/administration & dosage , Citric Acid/administration & dosage , Female , Humans , Male , Middle Aged , Organometallic Compounds/administration & dosage , Patient Satisfaction/statistics & numerical data , Picolines/administration & dosage , Polyethylene Glycols/administration & dosage , Preoperative Care/methods , Prospective Studies , Single-Blind Method , Smartphone , Video Recording/methods
3.
Gastrointest Endosc ; 69(6): 1111-6, 2009 May.
Article in English | MEDLINE | ID: mdl-19243765

ABSTRACT

BACKGROUND: The therapeutic approach in patients with sphincter of Oddi (SO) dysfunction (SOD) aims to reduce the resistance to the flow of bile or pancreatic juice. Vardenafil inhibits the activity of phosphodiesterase type 5 (PDE-5), which degrades cyclic guanossine monophosphate (cGMP) and results in relaxation of smooth muscle. OBJECTIVE: The present study was performed to determine the effects of vardenafil on SO motility in patients with suspected SOD. DESIGN: Prospective study. SETTINGS: Single university center. PATIENTS AND INTERVENTIONS: Twenty consecutive adult patients with suspected SOD were scheduled to undergo ERCP and SO manometry by standard methods. A second recording was performed in the same position 20 minutes after administration of 10 mg vardenafil dissolved in 10 mL saline solution into the duodenum through a conventional catheter. SO pressures and motor function were compared in all patients with suspected SOD before and after administration of vardenafil. RESULTS: After administration of 10 mg of vardenafil, the mean basal sphincter pressure was reduced from 59.5 to 26.9 mm Hg (P < .001), and the mean phasic amplitude was reduced from 132.2 to 66.2 mm Hg (P < .001). The mean phasic wave frequency was not changed after administration of vardenafil (7.2/min vs 6.6/min, respectively, P = .07). These results did not differ between SOD types. No significant difference in manometric data were detected before and after administration of vardenafil between cholecystectomy and gallbladder in situ groups. Transient headache was observed in 1 patient, and the procedure-related complication was post-ERCP pancreatitis (n = 2 [10%]). LIMITATIONS: The small sample size and uncontrolled study. CONCLUSION: Vardenafil inhibits SO motility in patients with suspected SOD and reduces basal SO pressure, without significant adverse effects.


Subject(s)
Common Bile Duct Diseases/drug therapy , Imidazoles/therapeutic use , Phosphodiesterase 5 Inhibitors , Phosphodiesterase Inhibitors/therapeutic use , Piperazines/therapeutic use , Sphincter of Oddi/drug effects , Vasodilator Agents/therapeutic use , Administration, Topical , Adult , Aged , Cholangiopancreatography, Endoscopic Retrograde , Constriction, Pathologic/drug therapy , Female , Humans , Imidazoles/adverse effects , Male , Manometry , Middle Aged , Phosphodiesterase Inhibitors/adverse effects , Piperazines/adverse effects , Postcholecystectomy Syndrome/drug therapy , Prospective Studies , Sphincterotomy, Endoscopic , Sulfones/adverse effects , Sulfones/therapeutic use , Triazines/adverse effects , Triazines/therapeutic use , Vardenafil Dihydrochloride , Vasodilator Agents/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...